跳至主要内容
临床试验/JPRN-jRCTb030190271
JPRN-jRCTb030190271已完成1 期

Clinical study on safety assessment of PRP therapy for development dysplasia of hip(PRP for hip dysplasia) - PRP for hip dysplasia

Homma Yasuhiro0 个研究点目标入组 1 人开始时间: 2020年3月31日最近更新:
适应症

试验速览

阶段
1 期
状态
已完成
发起方
入组人数
1

研究概览

简要总结

According to the experience in one patient in this study and the evidences reported recently,it was considered that the PRP injection for patient of hip dysplasia with endstage osteoarthritis was not scientifically validated. Thereby,this resarech was cancelled.

研究设计

研究类型
Interventional

入排标准

年龄范围
>= 20age old 至 ot applicable(—)
性别
All

入选标准

  • 1.Patients who have symptoms for more than 3 months
  • 2.Patients who have continued pain even after taking NSAIDs for 6 week or more and who can not use NSAIDs for asthma and digestive tract ulcer
  • 3. More than 20 years old
  • 4. Other , patients who the doctor has determined that it is suitable for this clinical study

排除标准

  • 1.Patients with a history of hip surgery
  • 2. Patients with abnormal platelet counts in peripheral blood
  • 3.Person who smokes a lot (Brinkmanindex>600)
  • 4. Treatment with anticoagulants(Warfarin)
  • 5. Uncontrolled diabetes mellitus : HbA1c not lower than 9.0% according to latest laboratory data obtained within 14 days before registration
  • 6. Patients with malignancy
  • 7. Patients less than 6 months after onset of cardiac infarction or cerebral infarction
  • 8. Predictive survival period is less
  • than 1 year
  • 9. Active infectious disease (HBV, HCV, HTLV-1, HIV, syphilis)
  • 10.Dialysis patients
  • 11. Compromised host
  • 12.Requiring continued use of oral corticosteroid therapy
  • 13. Less than 20 years old
  • 14.Doctor has determined that it is not suitable for this clinical study

研究者

发起方
Homma Yasuhiro

相似试验